• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Cytotoxic effect of hyperthermia and nitrocaphane on malignant HEp-2 cells].

作者信息

Li L G

机构信息

Radiobiology Laboratory, Henan Tumor Institute, Zhengzhou.

出版信息

Zhonghua Zhong Liu Za Zhi. 1989 Jan;11(1):31-3.

PMID:2776644
Abstract

Cytotoxic effect of hyperthermia combined with Nitrocaphane (NC) on HEp-2 cells was detected by colony formation assay. The results showed: 1. There was significant synergetic effect on survival fraction of HEp-2 cells when the heat was at 43 degrees C and 44 degrees C and NC at 0.5-4.0 micrograms/ml; 2. There was almost no effect on the cell survival when the heat was at 39 degrees C and 41 degrees C for 1 hr without NC; however, the cytotoxicity of NC (1.0 micrograms/ml) was enhanced when temperature was at 39 degrees C and 41 degrees C; 3. The sequence between heat and NC could influence the synergism. When the heat at 43 degrees C, 60 min and NC at 1.0 micrograms/ml were used simultaneously, the cytotoxicity was the strongest (SF = 0.025). When the heat was given 1-4 hr before or after the drug, the cytotoxicity was decreased. These results suggest that, over the range of 39-44 degrees C, the synergetic effects of hyperthermia and NC on malignant HEp-2 cells provide certain cell biologic basis for clinical application of local or systemic hyperthermia combined with NC.

摘要

相似文献

1
[Cytotoxic effect of hyperthermia and nitrocaphane on malignant HEp-2 cells].
Zhonghua Zhong Liu Za Zhi. 1989 Jan;11(1):31-3.
2
[Thermotolerant kinetics of HEp-2 cells and effect of thermotolerance on cytotoxicity of nitrocaphane].[人喉表皮样癌细胞的耐热动力学及热耐受对卡莫司汀细胞毒性的影响]
Zhonghua Zhong Liu Za Zhi. 1989 Mar;11(2):89-91.
3
Enhancement of nitrocaphane cytotoxicity by hyperthermia in vitro.热疗增强体外硝基卡烷的细胞毒性作用
Int J Hyperthermia. 1989 Jul-Aug;5(4):525-33. doi: 10.3109/02656738909140476.
4
Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.热疗对顺二氯二氨铂(II)、若丹明123(2)[四氯铂(II)]、若丹明123及四氯铂酸钾体内外作用的影响。
Cancer Res. 1988 May 1;48(9):2335-41.
5
In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.化学和热敏感性的体外测试系统:以人尤因肉瘤中的存活分数和细胞周期分布分析作为儿科肿瘤学中肿瘤的模型
Klin Padiatr. 2002 Jul-Aug;214(4):223-9. doi: 10.1055/s-2002-33192.
6
Arrhenius relationships from the molecule and cell to the clinic.从分子、细胞到临床的阿伦尼乌斯关系。
Int J Hyperthermia. 2009 Feb;25(1):3-20. doi: 10.1080/02656730902747919.
7
Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.热处理在儿童癌症中的作用:实体瘤细胞系对热化疗联合治疗的不同抗性特征
Pediatr Blood Cancer. 2005 Oct 15;45(5):663-9. doi: 10.1002/pbc.20266.
8
Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.热与一种醚脂类似物在人卵巢癌细胞中的细胞毒性相互作用。
Cancer Res. 1989 Nov 15;49(22):6285-9.
9
Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma.热疗单独或与顺铂及美法仑联合应用对人恶性黑色素瘤原代培养物的抗肿瘤活性。
Int J Cell Cloning. 1989 Nov;7(6):385-94. doi: 10.1002/stem.5530070606.
10
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.优化影响美法仑在自发性小鼠肿瘤中热增强作用的因素。
Cancer Chemother Pharmacol. 2006 Dec;58(6):719-24. doi: 10.1007/s00280-006-0229-2. Epub 2006 Apr 14.

引用本文的文献

1
Atherogenic dyslipidemia and diabetic nephropathy.动脉粥样硬化性血脂异常与糖尿病肾病。
J Nephrol. 2020 Oct;33(5):1001-1008. doi: 10.1007/s40620-020-00739-8. Epub 2020 Apr 23.